BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 35200157)

  • 1. Circular RNA circSHPRH inhibits the malignant behaviors of bladder cancer by regulating the miR-942/BARX2 pathway.
    Zuo L; Zhu Y; Han J; Liu H
    Aging (Albany NY); 2022 Feb; 14(4):1891-1909. PubMed ID: 35200157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CircHGS enhances the progression of bladder cancer by regulating the miR-513a-5p/VEGFC axis and activating the AKT/mTOR signaling pathway.
    Zhu Y; Zuo L; Xiong H; Li S; Chen R; Liu H
    Cell Cycle; 2023 Apr; 22(8):919-938. PubMed ID: 36617735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ZEB1-mediated biogenesis of circNIPBL sustains the metastasis of bladder cancer via Wnt/β-catenin pathway.
    Li Y; Kong Y; An M; Luo Y; Zheng H; Lin Y; Chen J; Yang J; Liu L; Luo B; Huang J; Lin T; Chen C
    J Exp Clin Cancer Res; 2023 Aug; 42(1):191. PubMed ID: 37528489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-3619-5p suppresses bladder carcinoma progression by directly targeting β-catenin and CDK2 and activating p21.
    Zhang Q; Miao S; Han X; Li C; Zhang M; Cui K; Xiong T; Chen Z; Wang C; Xu H
    Cell Death Dis; 2018 Sep; 9(10):960. PubMed ID: 30237499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CircRAPGEF5 sponges miR-582-3p and targets KIF3A to regulate bladder cancer cell proliferation, migration and invasion.
    Wang C; Yang X
    Int Immunopharmacol; 2024 Apr; 131():111613. PubMed ID: 38489970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CircITGA7 regulates malignant phenotypes in bladder cancer cells via targeting miR-330-3p/KLF10 axis.
    Yang XX; Wang C
    Kaohsiung J Med Sci; 2024 Apr; 40(4):324-334. PubMed ID: 38523597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N6-methyladenosine-modified CircPSMA7 enhances bladder cancer malignancy through the miR-128-3p/MAPK1 axis.
    Yi J; Ma X; Ying Y; Liu Z; Tang Y; Shu X; Sun J; Wu Y; Lu D; Wang X; Luo J; Liu B; Zheng X; Lin Y; Li J; Xie L
    Cancer Lett; 2024 Mar; 585():216613. PubMed ID: 38211649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. circSOBP Inhibits Bladder Cancer Proliferation and Metastasis by Regulating the miR-200a-3p/PTEN Axis and Participating in the Immune Response.
    Zhang Y; Li Z; Zhang Y; Shen C; Zhang Z; Ren X; Guo C; Yang S; Wang Z; Hu H
    Cell Transplant; 2023; 32():9636897231165874. PubMed ID: 37026617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. circMBOAT2 serves as the sponge of miR-433-3p to promote the progression of bladder cancer.
    Yu K; Liu M; Huang Y; Yu Q; Ma D; Dai G; Chen Y
    Pathol Res Pract; 2021 Nov; 227():153613. PubMed ID: 34563754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-621 inhibits cell proliferation and metastasis in bladder cancer by suppressing Wnt/β-catenin signaling.
    Tian H; Wang X; Lu J; Tian W; Chen P
    Chem Biol Interact; 2019 Aug; 308():244-251. PubMed ID: 31145890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circular RNA circFLNA inhibits the development of bladder carcinoma through microRNA miR-216a-3p/BTG2 axis.
    Lin S; Wang L; Shi Z; Zhu A; Zhang G; Hong Z; Cheng C
    Bioengineered; 2021 Dec; 12(2):11376-11389. PubMed ID: 34852712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circular RNA circUBXN7 represses cell growth and invasion by sponging miR-1247-3p to enhance B4GALT3 expression in bladder cancer.
    Liu H; Chen D; Bi J; Han J; Yang M; Dong W; Lin T; Huang J
    Aging (Albany NY); 2018 Oct; 10(10):2606-2623. PubMed ID: 30312173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CircSTK39 suppresses the proliferation and invasion of bladder cancer by regulating the miR-135a-5p/NR3C2-mediated epithelial-mesenchymal transition signaling pathway.
    Li Z; Wang Z; Yang S; Shen C; Zhang Y; Jiang R; Zhang Z; Zhang Y; Hu H
    Cell Biol Toxicol; 2023 Aug; 39(4):1815-1834. PubMed ID: 36538242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circular RNA_0001495 increases Robo1 expression by sponging microRNA-527 to promote the proliferation, migration and invasion of bladder cancer cells.
    Feng L; Fu D; Gao L; Cheng H; Zhu C; Zhang G
    Carcinogenesis; 2021 Aug; 42(8):1046-1055. PubMed ID: 34021307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CircZNF609 promotes bladder cancer progression and inhibits cisplatin sensitivity via miR-1200/CDC25B pathway.
    Feng D; Lv J; Li K; Cao Q; Han J; Yu H; Cheng Y; Zhuang J; Cai L; Yang H; Yang X; Lu Q
    Cell Biol Toxicol; 2023 Oct; 39(5):1-18. PubMed ID: 35567596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invasion-related circular RNA circFNDC3B inhibits bladder cancer progression through the miR-1178-3p/G3BP2/SRC/FAK axis.
    Liu H; Bi J; Dong W; Yang M; Shi J; Jiang N; Lin T; Huang J
    Mol Cancer; 2018 Nov; 17(1):161. PubMed ID: 30458784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. circ3323 Motivates Host Gene to Promote the Aggressiveness of Bladder Cancer.
    Wu X; Cao W; Lu C; Zuo L; Liu X; Qi M
    Biochem Genet; 2022 Dec; 60(6):2327-2345. PubMed ID: 35362879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circular RNA Pvt1 oncogene (CircPVT1) promotes the progression of papillary thyroid carcinoma by activating the Wnt/β-catenin signaling pathway and modulating the ratio of microRNA-195 (miR-195) to vascular endothelial growth factor A (VEGFA) expression.
    Zeng L; Yuan S; Zhou P; Gong J; Kong X; Wu M
    Bioengineered; 2021 Dec; 12(2):11795-11810. PubMed ID: 34927541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA miR143HG suppresses bladder cancer development through inactivating Wnt/β-catenin pathway by modulating miR-1275/AXIN2 axis.
    Xie H; Huang H; Huang W; Xie Z; Yang Y; Wang F
    J Cell Physiol; 2019 Jul; 234(7):11156-11164. PubMed ID: 30471109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circular RNA circ-ZKSCAN1 inhibits bladder cancer progression through miR-1178-3p/p21 axis and acts as a prognostic factor of recurrence.
    Bi J; Liu H; Dong W; Xie W; He Q; Cai Z; Huang J; Lin T
    Mol Cancer; 2019 Sep; 18(1):133. PubMed ID: 31481066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.